Risk of Stroke and Cardiovascular Events After Ischemic Stroke or Transient Ischemic Attack in Patients With Type 2 Diabetes or Metabolic Syndrome: Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial
Year: 2011
Type: article
Source: Archives of Neurology
Authors: Alfred Callahan, Pierre Amarenco, Larry B Goldstein, Henrik Sillesen, Mike Messig, Gregory P Samsa, Irfan Altafullah, Lucy Y Ledbetter, Mary J MacLeod, Russell Scott, Michael Hennerici, Justin A Zivin, K Michael A Welch
Institution: Vanderbilt University
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: type 2 diabetes, metabolic syndrome, ischemic stroke, transient ischemic attack, stroke recurrence, cardiovascular events, revascularization, atorvastatin, statin therapy, SPARCL trial, subgroup analysis, lipid-lowering therapy, secondary prevention, coronary artery disease, treatment effect heterogeneity, cardiovascular risk stratification
Open Access status: closed
OpenAlex ID: W2140681054
